Cancer's next frontier: addressing high and increasing costs.
作者信息
Elkin Elena B, Bach Peter B
机构信息
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 44, New York, NY 10065, USA.
出版信息
JAMA. 2010 Mar 17;303(11):1086-7. doi: 10.1001/jama.2010.283.
Abstract
摘要
相似文献
1
Cancer's next frontier: addressing high and increasing costs.
JAMA. 2010 Mar 17;303(11):1086-7. doi: 10.1001/jama.2010.283.
2
Medical care costs: how much welfare loss?
J Econ Perspect. 1992 Summer;6(3):3-21. doi: 10.1257/jep.6.3.3.
3
Is P4P really FFS?
JAMA. 2007 Oct 17;298(15):1797-9. doi: 10.1001/jama.298.15.1797.
4
Strategies to reduce cancer-care costs.
J Natl Cancer Inst. 2013 Feb 20;105(4):247-8. doi: 10.1093/jnci/djt020. Epub 2013 Jan 31.
5
And then there were none.
J Okla State Med Assoc. 2009 Sep;102(9):288-9.
6
Is high and growing spending on cancer treatment and prevention harmful to the United States economy?
J Clin Oncol. 2007 Jan 10;25(2):171-4. doi: 10.1200/JCO.2006.08.7536.
7
The economics of cancer care in the United States.
Am J Manag Care. 2012 Feb;18(1 Spec No.):SP38-9.
8
Reforming Medicare: impacts on federal spending and choice of health plans.
Health Aff (Millwood). 2001;Suppl Web Exclusives:W51-64. doi: 10.1377/hlthaff.w1.51.
9
Technology: redesigning the medical system.
Med Group Manage J. 1992 Nov-Dec;39(6):20-4.
10
Issues in health care: interventional pain management at the crossroads.
Pain Physician. 2007 Mar;10(2):261-84.
引用本文的文献
1
Vitamin D, Gut Microbiota, and Cancer Immunotherapy-A Potentially Effective Crosstalk.
Int J Mol Sci. 2025 Jul 22;26(15):7052. doi: 10.3390/ijms26157052.
2
Radiomics model based on computed tomography images for prediction of radiation-induced optic neuropathy following radiotherapy of brain and head and neck tumors.
Heliyon. 2024 Dec 24;11(1):e41409. doi: 10.1016/j.heliyon.2024.e41409. eCollection 2025 Jan 15.
3
Effect of applying digital health in palliative care for patients with advanced cancer: a meta-analysis and systematic review.
Support Care Cancer. 2024 Sep 17;32(10):664. doi: 10.1007/s00520-024-08866-9.
4
Care Delivery Interventions for Individuals with Cancer: A Literature Review and Focus on Gastrointestinal Malignancies.
Healthcare (Basel). 2023 Dec 22;12(1):30. doi: 10.3390/healthcare12010030.
5
Harnessing Real-World Evidence to Advance Cancer Research.
Curr Oncol. 2023 Feb 2;30(2):1844-1859. doi: 10.3390/curroncol30020143.
6
Implementation of an educational intervention to improve medical student cost awareness: a prospective cohort study.
BMC Med Educ. 2023 Jan 30;23(1):73. doi: 10.1186/s12909-023-04038-1.
7
Cost-Effectiveness Analysis of Sintilimab Combined with Chemotherapy Versus Chemotherapy Alone as the First-Line Treatment for Advanced Esophageal Cancer.
Front Pharmacol. 2022 Nov 28;13:934275. doi: 10.3389/fphar.2022.934275. eCollection 2022.
8
Time series models show comparable projection performance with joinpoint regression: A comparison using historical cancer data from World Health Organization.
Front Public Health. 2022 Oct 14;10:1003162. doi: 10.3389/fpubh.2022.1003162. eCollection 2022.
9
Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy as the first-line treatment for advanced esophageal cancer.
Cancer Med. 2023 Mar;12(5):6182-6189. doi: 10.1002/cam4.5350. Epub 2022 Oct 21.
10
Prostate Cancer Screening, Diagnostic, Treatment Procedures and Costs in Sub-Saharan Africa: A Situational Analysis.
Cancer Control. 2022 Jan-Dec;29:10732748221084932. doi: 10.1177/10732748221084932.
本文引用的文献
1
Cancer therapy costs influence treatment: a national survey of oncologists.
Health Aff (Millwood). 2010 Jan-Feb;29(1):196-202. doi: 10.1377/hlthaff.2009.0077.
2
Building a bridge from fragmentation to accountability--the Prometheus Payment model.
N Engl J Med. 2009 Sep 10;361(11):1033-6. doi: 10.1056/NEJMp0906121. Epub 2009 Aug 19.
3
Limits on Medicare's ability to control rising spending on cancer drugs.
N Engl J Med. 2009 Feb 5;360(6):626-33. doi: 10.1056/NEJMhpr0807774. Epub 2009 Jan 27.
4
Fostering accountable health care: moving forward in medicare.
Health Aff (Millwood). 2009 Mar-Apr;28(2):w219-31. doi: 10.1377/hlthaff.28.2.w219. Epub 2009 Jan 27.
5
Evaluation of trends in the cost of initial cancer treatment.
J Natl Cancer Inst. 2008 Jun 18;100(12):888-97. doi: 10.1093/jnci/djn175. Epub 2008 Jun 10.
6
Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population.
Cancer. 2008 May 15;112(10):2195-201. doi: 10.1002/cncr.23421.
7
Benefit design and specialty drug use.
Health Aff (Millwood). 2006 Sep-Oct;25(5):1319-31. doi: 10.1377/hlthaff.25.5.1319.
8
Does reimbursement influence chemotherapy treatment for cancer patients?
Health Aff (Millwood). 2006 Mar-Apr;25(2):437-43. doi: 10.1377/hlthaff.25.2.437.
9
The burden of illness of cancer: economic cost and quality of life.
Annu Rev Public Health. 2001;22:91-113. doi: 10.1146/annurev.publhealth.22.1.91.
Zotero 插件